Recent News for ACHL - Achilles Therapeutics plc

Date	Title
Sep 23	Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?
Aug 14	Achilles Therapeutics GAAP EPS of -$0.41
Aug 14	Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?
Aug 14	Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
May 22	Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines